Journal of Medicines Optimisation - Mar 2022

HYPERLINKS References and other resource material as appropriate can be accessed directly via hyperlinks in the Journal. SUBSCRIPTION The JoMO is free of charge to health professionals working for the NHS. To obtain a subscription, please go to www.pharman.co.uk an d click on the ‘PM Journals’ tab where subscription details can be found. REGISTRATION To receive the JoMO, please go to www.pharman.co.uk , c lick on the ‘PM Journals’ tab and follow the process for registration. ADVERTISEMENTS/ADVERTORIALS Please contact the Advertising Editor (see end of journal) for more information. Journal of Medicines Optimisation • Volume 8 • Issue 1 • March 2022 1 Editorial This is a moment for PM to take stock, and this edition includes articles about two new partnerships that will drive some of our future activity. In the first, Dr Gemma Quinn and Dr Liz Breen describe an arrangement with the University of Bradford that will assure the quality of PM’s offerings while helping the University of Bradford to devise different types of educational provision. Not everyone is able to commit to a substantial long-term course so alternative methods must be found to keep the pharmacy workforce upskilled, and together we aim to do that. In the second, our Chairman, Ted Butler, interviews Matt Salzmann of Viatris as the two companies agree a formal educational partnership. The performance of pharmacy during the pandemic has been little short of staggering, and we have another example of service provision during the pandemic to ease the load in general practice, this time from Rima Chauhan and Emily Shenton. Each time we carry such an article about the pandemic we imagine that it may be the last of its kind but further examples continue to appear. One of the projects for which PM is best known is CLIP®, our Clinical Leadership in Pharmacy Programme, and three of its alumni describe projects on which they have recently been working. We also have an article from Dr Emily Kennedy describing the use of mindfulness for pain, which may allow for changes in medicines use. We make no apology for returning to the matter of audit. There are many innovations but without regular checking that these are producing results we risk lapsing into guesswork. Mike Wilcock and his colleagues in Cornwall are at the forefront of this testing of practice against plan, and we have an example here, as they ask whether second line biologic therapies are being used in line with the agreed pathway. DISCLAIMER Published by: Pharman Limited, The Stable Yard, Vicarage Road, Stony Stratford, Bucks MK11 1BN Tel: 01371 874478 Homepage: www.jmedopt.com Email: [email protected] All rights reserved. No part of this publication may be reproduced, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of Pharman Limited. The views represented in the Journal are those of authors and not necessarily those of the Editor or Pharmacy Management. Pharman Ltd is not responsible for the content or accuracy of commercially generated material (e.g. advertisements, sponsored articles) but has the expectation that the originators of such material will ensure that it meets the requirements of the ABPI ‘Code of Practice for the Pharmaceutical Industry’ or other relevant guidance. Prescribing Information may be amended subsequent to publication of the journal so it is important to always consult the latest available version. Although great care has been taken to ensure the accuracy and completeness of the information contained in this publication, Pharman Limited nor any of its authors, contributors, employees or advisors is able to accept any legal liability for any consequential loss or damage, however caused, arising as a result of any actions taken on the basis of the information contained in this publication. Pharman Ltd is not responsible for the content of material that is available through hyperlinks. Efforts have been made to ensure that there is no infringement of copyright but please provide notification if any infringement is suspected. Pharman Limited welcomes requests for reproduction of the publication, in particular for educational purposes. Please contact the publishing office for information. Copyright© Pharman Limited The above composite logo is a registered Trade Mark owned by the publishers Pharman Limited